Related Experiment Videos
Protective effect of polymyxin B sulfate in experimental meningococcal infection in mice
Canadian Journal of Microbiology
|November 1, 1977
Abstract:
The mouse model of intraperitoneal meningococcal sepsis was used to evaluate the antiendotoxic activity of polymyxin B sulfate independent of its antibiotic effects. Administered either before or after the infective challenge therapeutic doses of polymyxin B sulfate produced small but significant increases in survival over unprotected animals. These results also suggest that endotoxin contributes to the outcome in this variety of Gram-negative infection.
Insights
Polymyxin B sulfate demonstrated antiendotoxic activity against meningococcal sepsis in mice, improving survival rates. This suggests endotoxin plays a key role in Gram-negative infections.
Area of Science:
- Microbiology
- Immunology
- Pharmacology
Background:
- Meningococcal sepsis is a severe Gram-negative infection.
- Polymyxin B sulfate possesses known antibiotic properties.
- Its antiendotoxic activity independent of antibiotic effects requires further investigation.
Purpose of the Study:
- To evaluate the antiendotoxic activity of polymyxin B sulfate.
- To assess its efficacy in a mouse model of intraperitoneal meningococcal sepsis.
- To determine if polymyxin B sulfate improves survival independent of its antibiotic action.
Main Methods:
- Utilized a mouse model of intraperitoneal meningococcal sepsis.
- Administered therapeutic doses of polymyxin B sulfate.
- Evaluated survival rates in treated versus untreated animals.
Main Results:
- Polymyxin B sulfate administration, both before and after infection, resulted in small but significant increases in survival.
- The observed survival benefit was independent of the antibiotic effects of polymyxin B sulfate.
- Endotoxin was implicated as a contributing factor to the disease outcome.
Conclusions:
- Polymyxin B sulfate exhibits antiendotoxic activity in meningococcal sepsis.
- Endotoxin is a significant contributor to the pathogenesis of this Gram-negative infection.
- These findings support the therapeutic potential of polymyxin B sulfate in sepsis beyond its antibiotic capabilities.